Bradley J Glass
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
Bradley J Glass is currently Director at Quest PharmaTech, Inc. and Director at Resverlogix Corp.
starting in 2025.
Formerly, Mr. Glass was General Counsel at Hepalink USA, Inc. Education includes undergraduate studies at Wabash College and graduate studies at Indiana University Maurer School of Law.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/08/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| QUEST PHARMATECH INC. | Directeur/Membre du Conseil | - |
| RESVERLOGIX CORP. | Directeur/Membre du Conseil | 18/11/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Resverlogix Corp.
Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
Quest PharmaTech, Inc.
Quest PharmaTech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products for the treatment of cancer | Commercial Services |
Wabash College
Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University Maurer School of Law
Indiana University Maurer School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national